Algert Global’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.72M Buy
+92,220
New +$2.37M 0.03% 762
2025
Q4
Sell
-99,200
Closed -$2.46M 1121
2025
Q3
$2.46M Buy
99,200
+36,330
+58% +$811K 0.04% 626
2025
Q2
$1.43M Buy
62,870
+54,550
+656% +$1.29M 0.03% 727
2025
Q1
$252K Sell
8,320
-93
-1% -$3.54K 0.01% 1040
2024
Q4
$334K Buy
+8,413
New +$379K 0.01% 974
2024
Q3
Sell
-9,305
Closed -$628K 1157
2024
Q2
$628K Buy
+9,305
New +$650K 0.02% 823
2022
Q2
Sell
-24,460
Closed -$1.6M 1181
2022
Q1
$1.6M Buy
+24,460
New +$1.42M 0.1% 314

Other funds holding ACHC

Algert Global's ACHC Position: Q2 2026 in Review

Algert Global opened a new position in Acadia Healthcare (ACHC) in Q2 2026: 92,220 shares worth $2.72M. The stake represents 0.03% of the portfolio and ranks #762 among its holdings. This is a return to the name: Algert Global previously reported a position in ACHC as recently as Q3 2025.

Algert Global first reported a position in ACHC in Q1 2022 and has held it in 7 quarters since. 314 funds tracked by Wall St. Rank hold ACHC as of Q2 2026.

  • Algert Global held 92,220 shares of Acadia Healthcare worth $2.72M as of Q2 2026.
  • Acadia Healthcare was a new Algert Global position in Q2 2026.
  • Acadia Healthcare made up 0.03% of Algert Global's portfolio in Q2 2026, its #762 holding.
  • Algert Global first reported a position in Acadia Healthcare in Q1 2022 and has held it in 7 quarters since.
  • 314 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.